BNP PARIBAS ARBITRAGE/CALL/SARTORIUS STEDIM BIO/250/0.025/21.06.24 Share Price

Warrant

NA3MB

NLBNPFR1W5B2

Market Closed - Euronext Paris 15:18:25 21/12/2023 GMT
0.835 EUR -3.47% Intraday chart for BNP PARIBAS ARBITRAGE/CALL/SARTORIUS STEDIM BIO/250/0.025/21.06.24
1 month+83.52%

Static data

Product typeWarrants
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer BNP Paribas BNP Paribas
NA3MB
ISINNLBNPFR1W5B2
Date issued 21/11/2023
Strike 250
Maturity 21/06/2024 (35 Days)
Parity 40 : 1
Emission price 0.28
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.875
Lowest since issue 0.365
Delta0.54x
Omega 3.772
Premium19.55x
Gearing7.02x
Moneyness 0.9496
Difference Strike 53.2
Difference Strike %+21.28%
Spread 0.05
Spread %5.75%
Theoretical value 0.8450
Implied Volatility 60.16 %
Total Loss Probability 61.87 %
Intrinsic value 0.000000
Present value 0.8450
Break even 283.80 €
Theta-0.02x
Vega0.02x
Rho0.01x

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
196.8 EUR
Average target price
250.1 EUR
Spread / Average Target
+27.07%
Consensus
  1. Stock Market
  2. Warrants
  3. NA3MB Warrant